Literature DB >> 30790617

Microcin J25 inhibits ubiquinol oxidase activity of purified cytochrome bd-I from Escherichia coli.

Adriana Emilce Galván1, Miriam Carolina Chalón1, Natalia Soledad Ríos Colombo1, Lici Ariane Schurig-Briccio2, Bernardo Sosa-Padilla3, Robert B Gennis2, Augusto Bellomio4.   

Abstract

Microcin J25 (MccJ25), an antimicrobial peptide, targets the respiratory chain but the exact mechanism by which it does so remains unclear. Here, we reveal that MccJ25 is able to inhibit the enzymatic activity of the isolated cytochrome bd-I from E. coli and induces at the same time production of reactive oxygen species. MccJ25 behaves as a dose-dependent weak inhibitor. Intriguingly, MccJ25 is capable of producing a change in the oxidation state of cytochrome bd-I causing its partial reduction in the presence of cyanide. These effects are specific for cytochrome bd-I, since the peptide is not able to act on purified cytochrome bo3.
Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Cytochrome bd-I; ROS; Redox peptide; Respiratory chain

Mesh:

Substances:

Year:  2019        PMID: 30790617     DOI: 10.1016/j.biochi.2019.02.007

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  9 in total

Review 1.  Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides.

Authors:  Xin Li; Siyao Zuo; Bin Wang; Kaiyu Zhang; Yang Wang
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

Review 2.  Bacterial Oxidases of the Cytochrome bd Family: Redox Enzymes of Unique Structure, Function, and Utility As Drug Targets.

Authors:  Vitaliy B Borisov; Sergey A Siletsky; Alessandro Paiardini; David Hoogewijs; Elena Forte; Alessandro Giuffrè; Robert K Poole
Journal:  Antioxid Redox Signal       Date:  2020-11-09       Impact factor: 7.468

3.  Microcin J25 Exhibits Inhibitory Activity Against Salmonella Newport in Continuous Fermentation Model Mimicking Swine Colonic Conditions.

Authors:  Sabrine Naimi; Séverine Zirah; Menel Ben Taher; Jérémie Theolier; Benoît Fernandez; Sylvie Françoise Rebuffat; Ismail Fliss
Journal:  Front Microbiol       Date:  2020-05-25       Impact factor: 5.640

4.  Formate dehydrogenase, ubiquinone, and cytochrome bd-I are required for peptidoglycan recognition protein-induced oxidative stress and killing in Escherichia coli.

Authors:  Des R Kashyap; Dominik A Kowalczyk; Yue Shan; Chun-Kai Yang; Dipika Gupta; Roman Dziarski
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

Review 5.  Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis.

Authors:  Erik J Hasenoehrl; Thomas J Wiggins; Michael Berney
Journal:  Front Cell Infect Microbiol       Date:  2021-01-11       Impact factor: 5.293

Review 6.  Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?

Authors:  Sapna Bajeli; Navin Baid; Manjot Kaur; Ganesh P Pawar; Vinod D Chaudhari; Ashwani Kumar
Journal:  Front Cell Infect Microbiol       Date:  2020-11-23       Impact factor: 5.293

Review 7.  Interventions in Nicotinamide Adenine Dinucleotide Metabolism, the Intestinal Microbiota and Microcin Peptide Antimicrobials.

Authors:  Fernando Baquero; Rosa Del Campo; José-Luis Martínez
Journal:  Front Mol Biosci       Date:  2022-03-14

Review 8.  Spotlight on the Selected New Antimicrobial Innate Immune Peptides Discovered During 2015-2019.

Authors:  Xiangli Dang; Guangshun Wang
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

9.  Engineering and characterization of human β-defensin-3 and its analogues and microcin J25 peptides against Mannheimia haemolytica and bovine neutrophils.

Authors:  Harpreet Dhingra; Kamaljit Kaur; Baljit Singh
Journal:  Vet Res       Date:  2021-06-10       Impact factor: 3.683

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.